Annual non current assets:
$944.70M+$97.52M(+11.51%)Summary
- As of today (May 29, 2025), ALNY annual long term assets is $944.70 million, with the most recent change of +$97.52 million (+11.51%) on December 31, 2024.
- During the last 3 years, ALNY annual non current assets has risen by +$109.97 million (+13.17%).
- ALNY annual non current assets is now at all-time high.
Performance
ALNY Non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly non current assets:
$945.55M+$855.00K(+0.09%)Summary
- As of today (May 29, 2025), ALNY quarterly long term assets is $945.55 million, with the most recent change of +$855.00 thousand (+0.09%) on March 31, 2025.
- Over the past year, ALNY quarterly non current assets has increased by +$109.77 million (+13.13%).
- ALNY quarterly non current assets is now -26.43% below its all-time high of $1.29 billion, reached on March 31, 2021.
Performance
ALNY quarterly non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Non current assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ALNY Non current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.5% | +13.1% |
| 3 y3 years | +13.2% | +12.1% |
| 5 y5 years | +39.1% | +36.1% |
ALNY Non current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +13.2% | at high | +13.1% |
| 5 y | 5-year | at high | +39.1% | -26.4% | +36.1% |
| alltime | all time | at high | >+9999.0% | -26.4% | +8500.6% |
ALNY Non current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $945.55M(+0.1%) |
| Dec 2024 | $3.30B(+10.5%) | $944.70M(+11.2%) |
| Sep 2024 | - | $849.62M(+1.5%) |
| Jun 2024 | - | $836.78M(+0.1%) |
| Mar 2024 | - | $835.78M(-1.3%) |
| Dec 2023 | $2.98B(+10.8%) | $847.18M(-0.8%) |
| Sep 2023 | - | $853.62M(-2.8%) |
| Jun 2023 | - | $878.35M(+3.2%) |
| Mar 2023 | - | $850.92M(-0.4%) |
| Dec 2022 | $2.69B(-4.1%) | $854.11M(+1.1%) |
| Sep 2022 | - | $844.41M(-1.7%) |
| Jun 2022 | - | $858.78M(+1.8%) |
| Mar 2022 | - | $843.87M(+1.1%) |
| Dec 2021 | $2.81B(+7.4%) | $834.73M(+4.7%) |
| Sep 2021 | - | $796.95M(+1.6%) |
| Jun 2021 | - | $784.27M(-39.0%) |
| Mar 2021 | - | $1.29B(+62.2%) |
| Dec 2020 | $2.61B(+52.4%) | $792.28M(-36.7%) |
| Sep 2020 | - | $1.25B(+3.2%) |
| Jun 2020 | - | $1.21B(+74.7%) |
| Mar 2020 | - | $694.85M(+2.3%) |
| Dec 2019 | $1.72B(+42.9%) | $679.27M(+5.4%) |
| Sep 2019 | - | $644.36M(-1.3%) |
| Jun 2019 | - | $652.64M(+4.9%) |
| Mar 2019 | - | $621.99M(+66.3%) |
| Dec 2018 | $1.20B(-32.0%) | $374.11M(+12.2%) |
| Sep 2018 | - | $333.53M(+16.3%) |
| Jun 2018 | - | $286.83M(+20.6%) |
| Mar 2018 | - | $237.84M(+3.4%) |
| Dec 2017 | $1.76B(+162.7%) | $229.99M(-37.0%) |
| Sep 2017 | - | $364.91M(-22.9%) |
| Jun 2017 | - | $473.57M(-11.8%) |
| Mar 2017 | - | $536.74M(-9.2%) |
| Dec 2016 | $671.88M(-39.2%) | $590.93M(+4.5%) |
| Sep 2016 | - | $565.35M(+14.4%) |
| Jun 2016 | - | $494.09M(+85.1%) |
| Mar 2016 | - | $266.88M(-5.1%) |
| Dec 2015 | $1.11B(+48.1%) | $281.12M(-28.7%) |
| Sep 2015 | - | $394.35M(-21.4%) |
| Jun 2015 | - | $501.62M(-6.9%) |
| Mar 2015 | - | $538.60M(+61.6%) |
| Dec 2014 | $746.37M | $333.23M(-2.9%) |
| Sep 2014 | - | $343.34M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $367.54M(-9.5%) |
| Mar 2014 | - | $406.23M(+144.0%) |
| Dec 2013 | $254.03M(+102.3%) | $166.50M(-33.0%) |
| Sep 2013 | - | $248.34M(+0.1%) |
| Jun 2013 | - | $248.20M(+7.2%) |
| Mar 2013 | - | $231.47M(+42.9%) |
| Dec 2012 | $125.56M(-17.4%) | $161.96M(+87.4%) |
| Sep 2012 | - | $86.42M(+10.6%) |
| Jun 2012 | - | $78.14M(-40.7%) |
| Mar 2012 | - | $131.76M(+1.4%) |
| Dec 2011 | $152.03M(-40.2%) | $129.89M(-0.3%) |
| Sep 2011 | - | $130.27M(+11.8%) |
| Jun 2011 | - | $116.49M(-1.6%) |
| Mar 2011 | - | $118.34M(-14.9%) |
| Dec 2010 | $254.14M(-13.4%) | $139.13M(-17.2%) |
| Sep 2010 | - | $167.98M(+0.8%) |
| Jun 2010 | - | $166.67M(-12.3%) |
| Mar 2010 | - | $190.10M(+1.2%) |
| Dec 2009 | $293.53M(-33.8%) | $187.85M(-29.8%) |
| Sep 2009 | - | $267.50M(+11.4%) |
| Jun 2009 | - | $240.23M(+77.7%) |
| Mar 2009 | - | $135.19M(+21.2%) |
| Dec 2008 | $443.12M(+11.4%) | $111.55M(-13.1%) |
| Sep 2008 | - | $128.40M(+336.5%) |
| Jun 2008 | - | $29.41M(-4.4%) |
| Mar 2008 | - | $30.78M(-67.9%) |
| Dec 2007 | $397.90M(+78.6%) | $95.89M(+249.2%) |
| Sep 2007 | - | $27.46M(+55.1%) |
| Jun 2007 | - | $17.70M(+1.6%) |
| Mar 2007 | - | $17.42M(+1.2%) |
| Dec 2006 | $222.78M(+170.3%) | $17.22M(-2.7%) |
| Sep 2006 | - | $17.70M(-2.0%) |
| Jun 2006 | - | $18.06M(+9.0%) |
| Mar 2006 | - | $16.57M(+4.0%) |
| Dec 2005 | $82.41M(+71.1%) | $15.93M(-3.7%) |
| Sep 2005 | - | $16.55M(-2.8%) |
| Jun 2005 | - | $17.02M(-3.4%) |
| Mar 2005 | - | $17.63M(-1.7%) |
| Dec 2004 | $48.18M(+99.2%) | $17.93M(+16.8%) |
| Sep 2004 | - | $15.35M(-14.6%) |
| Jun 2004 | - | $17.96M(+7.2%) |
| Mar 2004 | - | $16.75M(+52.4%) |
| Dec 2003 | $24.19M(+55.9%) | $10.99M |
| Dec 2002 | $15.52M | - |
FAQ
- What is Alnylam Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual non current assets year-on-year change?
- What is Alnylam Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly non current assets year-on-year change?
What is Alnylam Pharmaceuticals annual long term assets?
The current annual non current assets of ALNY is $944.70M
What is the all time high annual non current assets for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual long term assets is $944.70M
What is Alnylam Pharmaceuticals annual non current assets year-on-year change?
Over the past year, ALNY annual long term assets has changed by +$97.52M (+11.51%)
What is Alnylam Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of ALNY is $945.55M
What is the all time high quarterly non current assets for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly long term assets is $1.29B
What is Alnylam Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, ALNY quarterly long term assets has changed by +$109.77M (+13.13%)